News

This is the company behind USDC, the second-largest stablecoin in the world, and it raised $1.1 billion in its June IPO with a valuation just shy of $7 billion. Since then, the stock’s been surging.
Caris Life Sciences bumped up the pricing of its IPO to raise more than $494.1 million in its Nasdaq debut—well over the range it first proposed last week, in the vicinity of $400 million.
Caris prices US$494m Nasdaq IPO above the range 18 Jun 2025 09:27 | Robert Sherwood ...
There will be 24 million shares of SLDE released as part of the IPO. Slide is providing 16,666,667 of these shares, while stockholders are selling the remaining 7,333,333 shares.
Dan Sellers By Sydney Asher – Staff Writer, Dallas Business Journal Jun 18, 2025 Updated Jun 18, 2025 3:55pm CDT Preview this article 1 min ...
Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial public offering, aiming to raise up to $423.5 million. The $5.35 billion ...
Expected Price Movements Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $50.0 for Super Micro Computer ...
New capability leverages first-party data and will make Pinterest ads directly shoppable via Instacart. SAN FRANCISCO and CANNES, France, June 16, 2025/ PRNewswire/-- Instacart and Pinterest are ...
Chime Financial’s CHYM-6.14%decrease; red down pointing triangle stock jumped in its stock-market debut Thursday, the latest sign the U.S. initial public offering market is awakening. Shares of ...